Efficacy and tolerability of aripiprazole in outpatients with schizophrenia or schizoaffective disorder

被引：0
|
作者：
Shin, D. [1 ]
机构：
[1] Hongseong Med Ctr, Hongseong, South Korea
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2009年 / 19卷
关键词：
D O I：
10.1016/S0924-977X(09)70815-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S515 / S515
页数：1
相关论文
共 50 条
  • [31] A DOUBLE-BLIND COMPARISON OF THE SAFETY AND EFFICACY OF LURASIDONE AND ZIPRASIDONE IN CLINICALLY STABLE OUTPATIENTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER
    Cucchiaro, Josephine
    Potkin, S. G.
    Ogasa, M.
    Loebel, A.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 342 - 343
  • [32] Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder
    Potkin, Steven G.
    Ogasa, Masaaki
    Cucchiaro, Josephine
    Loebel, Antony
    SCHIZOPHRENIA RESEARCH, 2011, 132 (2-3) : 101 - 107
  • [33] Aripiprazole in bipolar disorder: clinical strategies to maximize efficacy and tolerability
    Andrea Fagiolini
    Annals of General Psychiatry, 9 (Suppl 1)
  • [34] Metformin for Weight Loss and Metabolic Control in Overweight Outpatients With Schizophrenia and Schizoaffective Disorder
    Jarskog, L. Fredrik
    Hamer, Robert M.
    Catellier, Diane J.
    Stewart, Dawn D.
    LaVange, Lisa
    Ray, Neepa
    Golden, Lauren H.
    Lieberman, Jeffrey A.
    Stroup, T. Scott
    AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (09): : 1032 - 1040
  • [35] Alcohol consumption and the CAGE test in outpatients with schizophrenia or Schizoaffective disorder and in the general population
    Etter, M
    Etter, JF
    SCHIZOPHRENIA BULLETIN, 2004, 30 (04) : 947 - 956
  • [36] Efficacy and tolerability of aripiprazole intramuscular as maintenance treatment in patients with paranoid schizophrenia
    Servan, B.
    Montes, A.
    Machin, M.
    Gomez, P.
    Garcia-Albea, J.
    Gonzalez, S.
    Ibanez, J.
    Moron, M. D.
    EUROPEAN PSYCHIATRY, 2017, 41 : S280 - S280
  • [37] Efficacy and tolerability of sodium valproate versus lithium carbonate in schizoaffective disorder
    Sulejmanpasic, G. A.
    Fisekovic, S.
    Ler, S.
    Frenjo, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S512 - S513
  • [38] Efficacy and tolerability of aripiprazole compared to perphenazine in treatment-resistant schizophrenia
    Kungel, M
    Ebrecht, M
    Modell, S
    Wagner, P
    Carson, W
    Marcus, R
    PHARMACOPSYCHIATRY, 2003, 36 (05) : 243 - 243
  • [39] Tolerability of Oral Ziprasidone in Children and Adolescents with Bipolar Mania, Schizophrenia, or Schizoaffective Disorder
    DelBello, Melissa P.
    Versavel, Mark
    Ice, Kathleen
    Keller, David
    Miceli, Jeffrey
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (05) : 491 - 499
  • [40] The comparison of efficacy between aripiprazole and haloperidol in treatment of chronic schizophrenia and schizoaffective disorder: results for 16-week clinical study
    Kim, J. G.
    Cho, D. H.
    Lee, S. J.
    Lee, J. K.
    Wang, K. S.
    Seo, Y. I.
    Choi, S. J.
    Joo, M. J.
    Kim, H. D.
    Lee, K. H.
    Kwon, Y. J.
    Han, K. R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S417 - S418
12345